Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Merck Suspends Sales of Zilmax Cattle Growth Supplement

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Merck (NYSE: MRK  ) announced today that it would suspend sales in the U.S. and Canada of Zilmax, a dietary supplement that promotes growth in beef cattle. The move follows an announcement from Tyson Foods (NYSE: TSN  ) on August 8 that it would stop accepting beef cattle fed with Zilmax beginning on September 6.

According to a report in Beef Magazine, Tyson sent a letter to its cattle suppliers entitled "animal well being," in which the company laid out its concerns about potentially deleterious effects in cattle from Zilmax supplementation. The letter elaborated:

There have been recent instances of cattle delivered for processing that have difficulty walking or are unable to move. We do not know the specific cause of these problems, but some animal health experts have suggested that the use of the feed supplement Zilmax... is one possible cause.

In its initial response on August 8 to Tyson's decision, Merck asserted its commitment to animal well-being, and defended the safety of Zilmax:

Worldwide regulatory agencies have reviewed extensive data on Zilmax and have concluded that use of Zilmax according to the label is safe in cattle. It is important to understand these data included rigorous animal health safety and well-being studies-conducted by University experts-that found the behavior and movement of cattle fed Zilmax is normal.

In its announcement today of the sales suspension, Merck characterized its decision as illustrative of its commitment to responsible beef. The company intends to conduct a scientific audit of Zilmax in conjunction with independent experts, following the full lifecycle of beef cattle to evaluate possible explanations for compromised mobility.

Zilmax sales in Canada and the U.S. were $159 million in 2012.

If you're on the lookout for high-yielding stocks outside of the health care sector, The Motley Fool's special free report, "Secure Your Future With 9 Rock-Solid Dividend Stocks," outlines the Fool's favorite dependable dividend-paying stocks. Grab your free copy today by clicking here.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2598957, ~/Articles/ArticleHandler.aspx, 9/28/2016 6:32:43 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:00 PM
MRK $63.30 Up +0.73 +1.17%
Merck and Co. CAPS Rating: ****
TSN $76.02 Up +0.30 +0.40%
Tyson Foods CAPS Rating: ****